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Management of Cysticercosis Cerebri 
William T. Couldwell, M.D and Michael L.J. Apuzzo, M.D. 
Infestation of the central nervous system (CNS) with 
the parasitic larval form of the cestode Taenia solium, Cys-
ticercosis Cerebri represents an endemic problem in much 
of the underdeveloped world. In such areas, up to 4% of 
the population rna y be affected by neufocysticercosis, and 
it accounts for up to 11 % of neurosurgical procedures per-
formed in selected centers. The disease remains endemic 
in Central and South America, Mexico, Eastern Europe, 
and Asia. With an increasing iInmigrant influx, however, 
more cases of this enigmatic entity will be presenting 
to neurosurgeons in developed nations; therefore main-
taining a high index of suspicion in persons of appropri-
ate ethnic background, and recognizing the potential dis-
ease spectrum is paramount for all neurosurgeons. 
Epidemiology 
Humans are the usual definitive hosts of the adult 
parasite; and when they become the inadvertent interme-
diate hosts for the parasite (usually porcine), nervous sys-
tem involvement may occur. Infestation with the larval 
form may occur with poor hygiene resulting in fecal-oral 
contan1ination, eating of contaminated foods, or pre-
sumably vvith reverse bowel peri~t<llsis permitting inges-
tion of ova released by resident adult intestinal forms. 
The ingested oncospheres may then traverse the gastric or 
upper intestinal mucosa, and by subsequent hemato-
genous spread, infest the CNS by lodging in small arteri-
oles at the gray / white interface. 
In addition to the eNS, the larval form has a propen-
sity to metastasize to subcutaneous tissue, both cardiac 
and skeletalmusculatllre, and intraocular locations. 
Diagnosis of Cysticercosis Cerebri 
The diagnosis of intracranial infestation is secured in 
most cases by a constellation of epiden1iologic, sylnpto-
matic, serologiC, and radiographic features consistent 
with the disease. In Ollr experience, the radiographic 
evaluation, especially computed tomography (CT) and 
more recently magnetic resonanCe imaging (MRI), offers 
the most specific diagnostic information. Other diagnostic 
~tudles, such as long bone radiographs to reveal soft tis-
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sue or muscle calcification, may be helpful, if only 
variably present. Examination of the stool for OVi1 is 
routinely performed, but the presence of ova is not 
pathognon1onic for determining intracranial involve-
ment. CSF or serum eosinophilia is indicative of a Pi1T8-
sitic infection but is neither specific nor sensitive. CSF or 
serum serological assays are known to be of limited diag-
nostic value, and are only positive in up to 60% of pTf>vi-
ously reported series of cysticercosis cerebri. In addition, 
the delay in obtaining results offers little advantage in the 
symptomatic patient. Newer serological methodologies 
show promise for increased diagnostic accuracy. A re-
cently published series from Mexico reports an 87% sensi-
tivity with CSF serology utilizing the Enzyme-l.inked 
lmmunoadsorbant Assay (ELISA), 
Spectrum of the Disease 
With hematogenous spread the larvae may infest the 
cerebral parenchyma; by presumpti ve choroid plexus 
seeding, the larvae may access the CSF and then (directed 
by bulk flow) lodge in the ventricles and basilar cisterns. 
With infection in these locations, ependymitis, basilar ara-
chnoiditis, and vasculitis may manifest either singularly 
or in combination. With vasculitic involvement. focal 
ischemia and cranial neuropathies may occur. The resul-
tant clinical presentation is therefore dependent on: 1) the 
locale of infection, 2) larval load, 3) potential presence of 
attendant hydrocephalus with intraventricular or basilar 
infection, and 4) the host immune response. 
In considemtion of the above, the clinical manifesta-
tions of the infection are protean. 
The live intraventricular cysts, having accessed the 
CSF pathways, are often noted throughout the ventricular 
system, suggesting a migratory lifestyle. Cysts harboring 
viable parasites may at various stages of volulne develop-
ment migrate through the ventricular systen1, occluding 
vital communication conduits and initiating frank acute 
hydrocephalus or impacting on neural elements and pro-
ducing focal deficits. Indeed, this has been our experi-
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Figure 1. MRI showing multiple intracranial infestations, isointense \vith CSF on T1 images. 
cncc, having witnessed cysts in all ventricles. 
Intraventricular cy,ts may prove to be particularly haz-
ardous, considering the potential for acute excursions of 
intracranial pressure. With larval deaLh dUll changes in 
cyst wall permeability, focal or generalized ependymitis 
filayoccur, with the potential for occlusion of ventricular 
outlets by this same mechanism_. 
It is a well recognized phenomenon that ventricular 
migration proceeds toward the fourth ventricle, either by 
grflvity or bulk flow; thus supporting the epidemiological 
observation that symptOlnatic intraventricular cysts occur 
most commonly in this location. Hydrocephalus (with 
hcndache of variable periods of lime pritlr to presenta-
tion) is a common clinical manifestation 9f intraventricu-
lar cysts. Third ventricular cysts are thus particularly 
ominous, offering the substrale fur tlcute neurological 
deterioration with aqueductal occlusion. 
Parenchymal disease, usually considered the benign 
end of the symptomatic spC'ctrum, uccurs with hemato-
genous spread of the larvae. The usual Cysticercosis 
cellulosae cysts in the brain parenchyma commonly range 
in size from 3 to 18 mIll, bUl oCG-'~iunally these lesions 
may reach symptomatic space-occupying proportions. 
The cysts contain 8. discreet marginal larvae or scolex 
which may be visualized on high-re~olution CT or MRI. 
Small asymptomatic lesions or those presen:ing with only 
EDITOR: 
seizure activity are usually managed expectantly in our 
institution if the epidemiologic, clinical, and radiographic 
characteristics corroborate the diagnosis of cysticercosis 
cerebrL These cysts usually become symptcnnatic during 
death of the larvae. During this stage, the dying parasite 
releases inflarnnlatory toxins. These in turn cause inflam-
mation of the surrounding parenchYlna with subsequent 
inbibition (intake) of fluid secondary to loss of osmotic 
regulation, thereby enlarging the cyst. The most common 
single presentatlOr. with parenchynlal disease is that 
of focal seizure activity. This has occurred in 92% of cases 
in son1e series, and up to 30 years after the original para-
sitic infestation. In instances of large symptomatic 
masses, however, surgical drainage or extirpation may be 
necessary. 
In contrast to the parenchyma! form of the disease, 
with CSF spread of the infestation, multiple cysts may 
form in grape-like clusters in the basilar cisterns, invoking 
hydrocephalus; basllar arachnoiditis; and cranial neu-
ropathies, These cysts do not contain a viable scolex. It is 
unknown whether or not this represents a successful inl-
munological response by the host. These aptly named 
Cysticercal racem0511S cysts portend J much more ominous 
prognosis; symptomatology is produced directly by local 
mass effect in cases of large cysts, indirectly by the distor-
tion of CSF conduits, or by vasculitic involvement. 
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Figure 2. MRI showing multiple discreet marginal intracranial lesions (scoleces). 
Radiographic Evaluation 
The presence of ventriculomegaly in the patient sus-
pected of having intracranial infestation with cysticerco-
sis is highly suggestive of intraventricular cystic lesions. 
These lesions are usually isodense with CSF 011 CT scans, 
and, as such, usually are not discernable without the ad-
ministration of a non-ionic conh'ast agent in the ventricular 
chamber. In the patient with a ventricular catheter placed 
for hydrocephalus, WE:' routmely instill 2 to 3 cc of contrast 
media to adequately outline any intraventricular lesions, 
which exclude the contrast. In the clinically stable patient, 
lVlRI is the preferred study to visualIze the lesions, which 
rna y also be isointense \vith CSF on routine T I images 
(Figure 1). In this instance, proton density imaging may 
enhance visualization. T2-\vcighted MRI or inh\lVenOlls 
contra3t-enhanced CT images may delnonstr<lte associated 
ependymitis with intrJventTicular disease. 
Parenchymal cysticercosis cysts may be classified into 
three evolutionary stages: FIRST STAGE, live parenchymal 
cysts: A clearly defined cyst may be identified on CT or 
MR images. The very thin capsule cannot be visualized. 
Cyst fluid is isodense/ isointense with CSF. The discreet 
marginal scolex may be identified (Figure 2). SECOND 
~lACE, dying parenchymal cysts: 1'he capsule thickens and 
becomes identifiable 011 Tl-weighted lVlRl. Cyst fluid be-
cnmes turbid and ll1ay be distinguished from eSF. Such 
changes liMy obscure resolution of the scolex. 1::nhance-
mcnt of the cyst wall on CT is evident, as with gadolin-
ium-DTPA on MRI, and may be an indication of an 
inflammatory response. THIRD STAGE, dead cysts: 1'he dead 
lar\'ae involute and calcify with time. CT appears to be 
superior to MRI in demonstrating the calcified scoleces. 
In cisternal cysts, \cuge lesions may mrmifest as space-
OCcupying lesions that ure usually isodense/isointense 
with CSF (Figure 3). Plain CT scans, while not optimal for 
their evaluation, may be augmented with the instillation JJ of a non-ionic contrast agent into the subarachnoid space. 
As with intraventricular disease, proton density and T1-
Weighted MRls are superior to T2-weighted images ror 
the evaluation of cisternal cysts; however, T2-weighted 
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images are useful for demonstrilting any attendant arach-
noiditis and tissue reaction. 
Surgical Options 
There (He il wide variety of surgical options available. 
These are listed in Table 1. 
Intraventricular cysts. Intr,lventricular cysts are har-
bored by some 15 to 20% of patients with neural compart-
ment infestation. One important feature noted in our 
experience has been the high incidence (38%) of rapid 
I 
Intraventricular Cysts: 
Lateral and Third Ventricular 




3. CSF Diversion 
Fourth V cntricu;<J.r 
'"1. Suboccipital Craniectomy 
2. CSF Diversion 
Parenchymal Cysts: 
"1. Stereotactic Aspiration 
2. Craniotomy 
Basilar Cisternal Cysts: 
: *1. Craniotomy 
L:: 2. CSF Diversion * preferred methodologies -------~ 
Table 1. Surgical options 
Figure 3. CT scan (left) and MRls showing large space-occupying cystic intracranial lesion that is isodense/isointense with CSF. 
clinical deterioration in this group of patients. In consid-
eration of this deterioration, we advocate aggressive sur-
gical intervention as a precautionary measure in this 
group. 
[n instances of intraventricular involvement, the two 
basic options are direct surgical attack on the cyst or a 
CSF diversion procedure to mitigate against impending 
hydrocephalus (Table 2). The potential for cyst migration 
must be assessed preoperatively as postural changes may 
cause possible frank migration bt't\veen ventricular 
chJmbers. 
In cases showing radiographic evidence of ependy-
mitis or arachnoiditis on contrast enhanced CT or inflam-
m(ltion indicated on MRls, we have found there may be 
some difficulty in excising intraventricular lesions. In'this 
inst(lnce, strong consideration should be given to a pri-
lllary CSF diversion procedure. In the absence of radio-
graphic infl(lmmatioIl, direct ~urgical excision should be 
the optimum strategy with simple intraventricular cysts 
to decrease the risk of acute hydrocephalus while obviat-
ing the need for a shunting device. 
Should the decision be made to attempt primary cyst 














Table 2. Surgical optioll" for intr.;lvenLriculdr lesion::.. 
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detennined. Cysts in the lateral and third ventriculi1r 
chambers are well-suited to endoscopic aspiration utiliz-
ing specifically designed ventriculoscopic methodologies. 
These techniques have proven extremely useful; the con-
tents of the cyst are aspirated under direct vision in the 
lateral and third ventricular chambers. In cases of intra-
ventricular rupture, there have been no untoward effects. 
The concurrent use of high-potency glucocorticoids and 
generous ventrkular irrigation with tepid lactated 
Ringer's solution are strongly :-ecommended. 
If stereotactic drilinage uf the cyst is not possible, then 
the open surgical corridor should be chosen based pri-
marily on the location of the cyst. Usually a transcortical 
lTIicrosurgical approach is utilized to access lateral ven-
tricular cysts, and a transcallosal interfornicial corridor is 
the preferred approach to third ventricular lesions. In all 
cases, a generous fenestration of the septum pellucidum 
is done to ell sure adequate bilateral drainage through a 
unilateral approach. 
In the absence of overt radiographic evidence of 
inflammation, fourth ventricular cysts are easily ex-
tractable by suboccipital craniecto1l1Y, separation of the 
cerebellar tonsils, and gentle ventricular irrigation. 
In cases of multiple intrilventricular lesions or in 
cases with overt radiographic evidence of ependymitis or 
basilar arachnoiditis (often associated \vith racenlOse 
cysts), \ve advocate a. primary CSF diversion procedure. 
MultIple conduits may be necessary in cases with a locu-
lated ventricul2r system secondary to multiple cysts or 
attendant ependymitis. In this instance, there is a prob-
lem in maintaining patent shunt systems. There also 
exists the possibility of local expansion of the intraven-
tricular lesions causing focal compression (especially in 
cases of third or fourth ventricular involvement) , which 
would require an additional direct drainage or excision. 
Parenchymal cysts. Our experience with parenchy-
mal sPJce-occupying lesions shows 8.40/(. of patients with 
newly diagnosed cysticercosis cerebri manifesting symp-
tomatology from large cisternal and parenchymal cysts. 
These cysts may ari~e anywhere in tl'_e cerebrum, must 
commonly at the level of the gray/white interface, and as 
such, they often defy easy surgical accesS. 
\lVith the potential for recurrence of the cyst in the 
absence of total cyst excisiun, and with the realizalion lhal 
the life span of the larvae may be up to ten years, we 
manage all large parenchymal lesions primarily with 
stereotactic aspiration of the cyst, sirI1ultaneollsly in1-
planting indwelling cyst catheter-reservoir systems. This 
enables repeat aspiration of the cyst in the event of symp-
tomatic recurrence. Althuugh craniutUIIlY uffers lIte po-
tential advantage of open surgical excision of the entire 
cyst wall and scolex, which thus decreases the rate of cyst 
recurrence, it has been unly uf marginal efficacy in our 
experience. Attempted craniotomy with excision of the 
cyst has been associated with unacceptable morbidity and 
frequent cyst recurrence. Clinically, the cyst wall is often 
found to be tenacious in its adherence to surrounding 
neural and vascular elements, which may preclude total 
removaL In our series, the patientti w hu were managed by 
primary craniotomy all required subsequent drainage 
procedures; this is in direct contrast to the patients who 
underwent an initial stereotactic procedure with place-
ment of a cyst catheter-reservoir system. All of these 
patients were managed successfully by percutaneous as-
piration of their reservoir with minimum morbidity. In 
comparison to other cystic lesions, the cysticercal walls 
are not difficult to puncture. This obviates the need to use 
excessively sharp probes, which may cause potential vas-
ClIlar injury. Therefore, we advocate the use of stereotac-
tic methodologies in the initial management of all large 
intra-axial lesions, 
Cisternal Cysts. Basilar cisternal cysts may reach 
large space-occupying proportions They may cause 
synlptams by direct impact on surrounding neural ele-
ments or indirectly by obstructing CSF conduits. In con-
trast with intra parenchymal cysts, cisternal lesions may 
often be easily renloved with gentle traction and irriga-
tion. In the absence of overt radiographic evidence of 
surrounding arachnoiditis (e.g., CT contrast enhance-
ment), we advocate open craniotomy and evacuatiort of 
these large lesions. Indeed, in the majority of cases, the 
removal of these cysts may be performed without vio-
lation of the cyst wall. This obviates the potential for 
chemical meningitis as reported by other authors. In our 
experience, with the concurrent use of high potency glu-
cocorticoids, rupture of intraventricular or cititernal cysts 
has not been associated with inflammatory reactions as 
observed by others. Madrazo et aI., having noted this 
complication with intraoperative rupture uf oIlly illtra-
ventricular cysts, have postulated that the contents of the 
dead cysticercus (c. racemasus) may be nontoxic as op-
posed to that of the live cysticercus (c. cellulosae). 
Outcome 
There is marked disparity in reported outcome of 
Cysticercosis cerebri in the literature. This represents the 
spectrum of clinical and pathophysiological consequences 
of infection, The literature also reflects a skewed sample 
of the disease populace. The outcome is primarily de-
pendent on the location and extent of intracranial infesta-
tion. Dixon and Lipscomb, in following 450 patients with 
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lhe disease, delermined an overall case fata~ity of cerebral 
cysticercosis of 10.4% (in some cases over a period of 30 
years). 
Inlraventricular disease, in the absence of attendant 
ependymitis or basilar cisternal involven1ent, is easily 
amenable to surgical intervention. The presence of iso-
lated intraventricular involvement portends a satisfactory 
outcome in the majority of cases, managed either by pri-
mary cyst extraction or diversion. Unfortunately, as is 
oflen the case, patients may harbor the disease in lTIultiple 
intracranial locations. Thus, the ultimate outcome is con-
tingent on the possible presence of basilar involvement, 
which could adversely affect the prognosis of a patienl 
who would otherwise remain clinically stable, 
Our experience with parenchymatous disease indi-
cates that this is a relatively benign infestation in the ma-
jority of cases. If the disease is limited to the parenchyma, 
and the presentation is one of focal neurological deficit or 
seizure, the prognosis is better than in the patient whu 
presents with signs or symptoms of raised intracranial 
pressure. Even in the small percentage of patients who 
harbor sizeable lesiuns requiring surgical drainage, the 
ultimate outcome will be limited by the concomitant basi-
lar involvenlent. In our series, the patients with lesions 
who were managed by the implantatiun of cyst catheter-
reservoir systems all improved clinically. This was in di-
rect contrast to those patients who underwent primary 
craniotumy, all uf whom required an addilional surgical 
intervention for cyst recurrence. It was necessary, how-
ever, to aspirate the cyst-reservoir percutaneously in this 
group on several uccasion::., Overall, the patients experi-
enced an 88% improvement in the neurological deficit, 
and a 75% improvement in symptomatology in those 
cases rnanageu surgically in our inslilution. The Inedian 
follow-up for this group exceeded 36 months. There does 
exist a very small subgroup of patients with extensive 
parenchynlal infection who may presenl with a cEnical 
meningo-encephalitis and who may follow a much more 
malignant clinical course. 
It is generally recognized that in the basal cisternal 
form of infestation (e. racemosus), the prognosis is de-
pendent on the presence of associated arachnoiditis and 
vasculitis, often reflected in a significant CSF pleucytosis. 
The disease process defies surgical cure, with vasculitis 
leading to cranial nerve palsies and ischelnia. In these 
cases, the prognutiis is guanled, uften with a relentless 
deterioration in clinical course despite CSF diversion, 
Medical Therapy 
The anthelminthic agent Praziquantel (Biltricide, 
Miles Pharmaceuticals I has shown promise in the medical 
treatment of intracranial cysticercosis, This heterocycliC 
pyrazino-isoquinolone derivative has been demonstrated 
in preliminary studies to be effective against parenchy-
matous lesions. In our institution, all patients with symp-
tomatic, multiple, active parenchymal lesions are treated 
with a two-week course of the drug. Should symptomatic 




then be contemplated in the patienl with large space-
occupying cysts. Concurrent treatment 'with cortico-
steroids is recommended. 
Another advantage in using this anthelminthic is 
sterilization of the intestinal tract where the adult form 
may be harbored, a potential source of reinfection with 
the ova. Patients with multiple, sinall, active lesions not 
amenable to surgical methodologies deserve a course of 
treatment. Its use as an adjuvant in large space-occu-
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Answer questions on response card for volume 011, lesson 19 
IMPORTANT: MARK ONLY ONE OVAL AND USE NUMBER 2 PENCIL ONLY 
Response card must be mailed on or before December 6, 1989 
1. The larval form of the cestode Taenia so/ium may infest 
the ventricular, parenchymal, cisternal, and spinal 
spaces. 
True or False? 
2, The most common time for symptomatic manifestation 
of the parenchymal form of infection is with death of 
the larvae. 
True or False? 
3. Parenchymal involvement is the most benign manifes-
tation of intracranial infestation. 
True or False? 
4. Intraventricular cysts are readily visualized on unen-
hanced CT scans. 
True or False? 
5. Craniotomy is the preferred surgical treatment for in-
traparenchymal disease. 
True or False? 
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6. Craniotomy is the preferred surgical methodology for 
large cisternal lesions. 
True or False? 
7, The absence of radiographically discernable intraven-
tricular cysts eliminates the potential for the develop-
ment of hydrocephalus. 
True or False? 
8. All patients with intraventricular cysts are candidates for 
surgical removal of the lesion. 
True or False? 
9. Craniotomy for excision of parenchymal lesions is 
associated with potential recurrence. 
True or False? 
10. Praziquantel has been demonstrated to be efficacious 
in Cisternal and intraventricular disease. 
True or False? 
,~ 
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